AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 258: G352-G357, 1990;
0193-1857/90 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pique, J. M.
Right arrow Articles by Whittle, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pique, J. M.
Right arrow Articles by Whittle, B. J.

AJP - Gastrointestinal and Liver Physiology, Vol 258, Issue 3 352-G357, Copyright © 1990 by American Physiological Society


ARTICLES

Influence of morphine or capsaicin pretreatment on rat gastric microcirculatory response to PAF

J. M. Pique, J. V. Esplugues and B. J. Whittle
Gastrointestinal Unit, Hospital Clinic, Barcelona, Spain.

Capsaicin pretreatment, which destroys primary sensory afferent neurons, or morphine, which can inhibit peripheral sensory neurons, augments gastric damage induced by platelet-activating factor (PAF). The concurrent effects of such treatments on the changes in gastric mucosal blood flow (GMBF), as estimated by hydrogen gas clearance, and in systemic arterial blood pressure (BP) have now been determined in anesthetized rats. Intravenous infusion of PAF (25 and 50 ng.kg-1.min-1 for 30 min) induced dose-related histologically assessed mucosal damage, which was significantly potentiated by neonatal capsaicin pretreatment. Capsaicin pretreatment did not affect resting BP or GMBF or the fall in BP induced by PAF but did significantly potentiate the PAF-induced reduction in GMBF. Likewise, morphine (1.5 mg/kg iv) did not affect resting BP or GMBF or the fall in BP but did enhance the reduction in GMBF and potentiated the mucosal damage after PAF infusion; both of these effects were abolished by the opioid-antagonist naloxone (1 mg/kg iv). These findings indicate that the deleterious gastric microcirculatory changes induced by PAF are enhanced by functional ablation of sensory afferent neurons and by morphine, which may act on these neurons; these effects may therefore underlie the potentiation of gastric damage. Such local sensory neurons thus appear to be involved in the regulation of local protective microvascular responses to noxious challenge.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online